COVID-19 · COVID-19 Vaccine

CDC Real-World Study Confirms Protective Benefits of the COVID-19 Vaccines

CDC Real-World Study Confirms Protective Benefits of the COVID-19 Vaccines – A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care personnel, first responders, and other essential workers. #COVID19Vaccine

CDC Real-World Study Confirms Protective Benefits of the COVID-19 Vaccines

Study involved health care personnel, first responders, and essential workers in six states.

These groups are more likely than the general population to be exposed to the virus because of their occupations.

CDC Real-World Study Confirms Protective Benefits of the COVID-19 Vaccines - A new CDC study provides strong evidence that mRNA COVID-19 vaccines are highly effective in preventing SARS-CoV-2 infections in real-world conditions among health care personnel, first responders, and other essential workers. #COVID19Vaccine
Photo by Nataliya Vaitkevich on Pexels.com

The study looked at the effectiveness of Pfizer-BioNTech and Moderna mRNA vaccines in preventing SARS-CoV-2 infections among 3,950 study participants in six states over a 13-week period from December 14, 2020 to March 13, 2021.

Results showed that following the second dose of vaccine (the recommended number of doses), risk of infection was reduced by 90 percent two or more weeks after vaccination. Following a single dose of either vaccine, the participants’ risk of infection with SARS-CoV-2 was reduced by 80 percent two or more weeks after vaccination.

It takes about two weeks following each dose of vaccine for the body to produce antibodies that protect against infection. As a result, people are considered “partially vaccinated” two weeks after their first dose of mRNA vaccine and “fully vaccinated” two weeks after their second dose. These new vaccine effectiveness findings are consistent with those from Phase 3 clinical trials conducted with the vaccines before they received Emergency Use Authorizations from the Food and Drug Administration. Those clinical trials evaluated vaccine efficacy against COVID-19 disease, while this study evaluated vaccine effectiveness against infection, including infections that did not result in symptoms.

“This study shows that our national vaccination efforts are working. The authorized mRNA COVID-19 vaccines provided early, substantial real-world protection against infection for our nation’s health care personnel, first responders, and other frontline essential workers,” said CDC Director Rochelle P. Walensky, MD, MPH. “These findings should offer hope to the millions of Americans receiving COVID-19 vaccines each day and to those who will have the opportunity to roll up their sleeves and get vaccinated in the weeks ahead. The authorized vaccines are the key tool that will help bring an end to this devastating pandemic.”

One of this study’s strengths is its design: participants self-collected nasal swabs each week for RT-PCR laboratory testing, regardless of whether they had developed symptoms of illness.  Researchers were able to look for evidence of SARS-CoV-2 infection irrespective of symptoms. A small number (10.7 percent) of infections in this study were asymptomatic (i.e., did not result in symptoms). However, the majority of infections (58 percent) occurred among people whose infections were identified by testing before they developed symptoms or knew they were infected. The study demonstrates that these two mRNA vaccines can reduce the risk of all SARS-CoV-2 infections, not just symptomatic infections.

How to prepare for your Covid-19 Vaccine

This is important because preventing both asymptomatic and pre-symptomatic infections among health care workers and other essential workers through vaccination can help prevent the spread of SARS-CoV-2 to those they care for or serve. Findings from this study complement earlier reports that these two mRNA COVID-19 vaccines can reduce both asymptomatic and symptomatic SARS-CoV-2 infections.

This study also provided positive news about partial (one-dose) vaccination. The one-dose VE estimate of this study (80 percent) is consistent with other recent VE studies following the first dose of Pfizer-BioNTech vaccine among health care providers.  Studies conducted in the United Kingdom and Israel showed that one dose was about 70 percent and 60 percent effective, respectively, against SARS-CoV-2 infection.  The current results provide reassurance that people start to develop protection from the vaccine two weeks after their first dose. The greatest protection was seen among those who had received both recommended doses of the vaccine.

This CDC study was conducted through the HEROES-RECOVER network, a network of prospective cohorts that share a common protocol and methods. This network is part of a vaccine effectiveness surveillance system made possible by federal pandemic flu preparedness funding.

This study is the first of many planned COVID-19 vaccine effectiveness studies CDC is conducting to evaluate the benefits of COVID-19 vaccines in various populations and across different outcomes, such as preventing infections, doctor’s visits, hospitalizations, or deaths. Results from these studies assist the medical and public health experts on the Advisory Committee on Immunization Practices and CDC to make important vaccine policy decisions aimed at saving lives.


U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.


Upcoming Events

This is a list of the upcoming events that Steve Sews will be at. If you know of one in the East Tennessee area, let me know.

None at this time. Check back later.


Meet …

Meet the staff and/or equipment for Steve Sews.

SUBSCRIBE TODAY!

Don’t miss a single blog post about sewing, quilting, crafts, and recipes! Plus so much more!

Please like, subscribed, comment, share

Follow on WordPress

Follow Steve Sews Stuff on WordPress.com

Follow Steve Sews Stuff on Social Media:

You can also choose to follow Steve Sews Stuff on social media as well. (@SteveSews2)


Below are some examples of blog entries from all blogs that I do. (Courageous Christian Father, Steve Sews Stuff and SteveZ DesignZ).

Recent Feed of All of Steve’s Blogs

Loading RSS Feed


Recent Posts on Steve Sews

Below is a list of the most recent blog posts found on Steve Sews for you to check out.

  • A Feline Tale of Quilting Mastery
    A Feline Tale of Quilting Mastery — In the quaint town of Purrington, nestled amidst rolling hills and meandering streams, lived a remarkable feline named Whiskers. Whiskers wasn’t your ordinary cat; he possessed a unique talent that set him apart from his furry companions—he was a master quilter.
  • The Sizzling Benefits and Uses of Saving Bacon Grease
    The Sizzling Benefits and Uses of Saving Bacon Grease — Bacon grease is more than just a byproduct of cooking bacon; it’s a versatile kitchen staple with a multitude of uses. Here’s why you should think twice before discarding it.
  • Places to buy fabric
    Places to buy fabric — Besides your local fabric & quilt shops ran by locals, there are National chains you can find fabric at.
  • Sewing in Case Binding in the Printing Industry
    Sewing in Case Binding in the Printing Industry — In bookmaking, the term “case binding” often conjures images of stately hardcover books, their spines lined up on library shelves, exuding a sense of permanence and tradition. But what many may not realize is the intricate process of sewing that lies at the heart of this bookbinding method—a process that not only holds the pages together but also connects us to a centuries-old craft.
  • JoAnn Fabric and Crafts is filing Bankruptcy
    JoAnn Fabric and Crafts is filing Bankruptcy — JoAnn Fabric and Crafts, the beloved destination for craft enthusiasts and fabric aficionados, has filed for Chapter 11 bankruptcy protection. This development has sent ripples through the retail sector, particularly among those who have cherished the brand for its quality products and community presence.

Clipart: UnsplashPixabayPexelsOpenverseAdobe ExpressAdobe StockFreePikMetroCreative, Wonder AI, Algo AI and more. This site uses Amazon Affiliate Ads & Google Ads.


About Post Author


Your Comment Is Appreciated!

This site uses Akismet to reduce spam. Learn how your comment data is processed.